Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAPS: Smoking Asthmatics Pilot Study
NCT01696214Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Oct 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of montelukast, theophylline and ipratropium bromide in asthma (4 arms), sponsored by University of California, San Diego. Primary endpoint: Asthma Control Test at 24 weeks. Started Oct 2012; status: completed.
02
Drugs
montelukasttheophyllineipratropium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01696214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696214.